Taking the Wheel in CAR T: Expert Guidance for Identifying and Engaging DLBCL and FL Patients

Webinar/Online

Tuesday, November 18, 2025 at 2:00pm ET - 2:30pm ET
Add this event to your calendar

Info

Topic

Join us for a live webinar where expert faculty will provide actionable insights on improving patient identification and engagement for CAR T-cell therapy in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). The session will feature key findings from a quality improvement initiative, along with case discussions designed to support you synthesize the latest clinical evidence for CAR T-cell therapies to enhance patient eligibility identification. Additionally, we will introduce the Essentials of CAR T-Cell Therapy in DLBCL/FL and Shared Decision-Making Strategies Toolkit and the CAR T-Cell in R/R DLBCL & FL Shared Decision-Making Patient Education Resource to support patient education and engagement strategies. Don't miss this opportunity to refine your approach and improve patient outcomes with CAR T-cell therapy.

Credits Offered

This event offers 0.5 contact hours to attendees.
Accreditation Info: AANP.

Additional Information

Join us for a live webinar where expert faculty will provide actionable insights on improving patient identification and engagement for CAR T-cell therapy in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).

Speakers

Michael Jain
Michael Jain MD, PhD

ICE-T Medical Director at the Moffitt Cancer Center Department of Blood and Marrow Transplant and Cellular Immunotherapy

Sairah Amed
Sairah Amed MD

Sairah Ahmed, M.D.
Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Director of CART Program, The University of Texas MD Anderson Cancer Center, Houston, TX

Douglas S Burgoyne
Douglas S Burgoyne PharmD, FAMCP

Adjunct Professor
Department of Pharmacotherapy
University of Utah College of Pharmacy
Salt Lake City, UT

Interested In Attending This Event?